Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Necrotic ulcer on the chin of a previously healthy 38-year-old woman

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Comorbidities in vitiligo: comprehensive review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Patient-reported outcomes (PROs) in chronic urticaria

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Autoinflammatory syndromes associated with hidradenitis suppurativa (HS) and/or acne are rare but potentially debilitating disorders if not diagnosed and treated correctly. They share a common pathogenesis involving a dysregulated innate immune system with abnormal interleukin (IL)-1 signaling leading to sterile neutrophilic inflammation. The clinical features are recurrent episodes of fever, painful arthritis, and skin lesions consistent with HS, acne, and pyoderma gangrenosum (PG) accompanied by elevated systemic inflammatory markers in blood. So far, several clinically different syndromes have been reported in the literature including pyoderma gangrenosum, acne, and pyogenic arthritis (PAPA), pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH), pyoderma gangrenosum, acne, and spondyloarthritis (PASS), pyoderma gangrenosum, acne, pyogenic arthritis, and hidradenitis suppurativa (PAPASH), psoriatic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PsAPASH), and pyoderma gangrenosum, acne, and ulcerative colitis (PAC). The rarity of the syndromes complicates the establishment of evidence-based treatment guidelines. Furthermore, treatment can be challenging due to lack of response to standard treatment modalities. Therefore, it is important to increase the awareness about these diseases in order to optimize disease management and ultimately improve the quality of life of patients.

OriginalsprogEngelsk
TidsskriftInternational Journal of Dermatology
Vol/bind56
Udgave nummer8
Sider (fra-til)811-818
Antal sider8
ISSN0011-9059
DOI
StatusUdgivet - aug. 2017

ID: 52410083